Amany A. Abdin

582 citations
24 papers · 468 indexed · h-index 14
Topics
Liver Disease Diagnosis and Treatment (3 papers)Biochemical Acid Research Studies (3 papers)Coenzyme Q10 studies and effects (2 papers)

In The Last Decade

Amany A. Abdin

22 papers receiving 451 citations

Peers

Amany A. Abdin
Comparison fields: 5 of 84
  • Molecular Biology 181
  • Neurology 60
  • Epidemiology 54
  • Complementary and alternative medicine 53
  • Surgery 51
Replace Inhae Kang with:
Inhae Kang South Korea
Bidur Bhandary South Korea
Lin Zou China
Elham Hakimizadeh Iran
Shenghui Chen China
Peng Liang China
Xueyu Fan China
Renad Mammadov Türkiye
Silvia Grottelli Italy
Yuh-Lin Wu Taiwan
Amany A. Abdin relative to Inhae Kang South Korea Inhae Kang's profile →
Citations per field
00.5×3.2×
Inhae Kang · 1×
Citations per year

Countries citing papers authored by Amany A. Abdin

Since Specialization
Citations

This map shows the geographic impact of Amany A. Abdin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amany A. Abdin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amany A. Abdin more than expected).

Fields of papers citing papers by Amany A. Abdin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amany A. Abdin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amany A. Abdin. The network helps show where Amany A. Abdin may publish in the future.

Co-authorship network of co-authors of Amany A. Abdin

This figure shows the co-authorship network connecting the top 25 collaborators of Amany A. Abdin. A scholar is included among the top collaborators of Amany A. Abdin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amany A. Abdin. Amany A. Abdin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 2
4 9
5 25
6 0
7 16
8 21
9 39
10 61
11 1
12 17
13 37
14 24
15 53
16 18
17 66
18 23
19 1
20 7

About Amany A. Abdin

Amany A. Abdin is a scholar working on Clinical Biochemistry, Biochemistry and Biological Psychiatry, having authored 24 papers that have together received 468 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (3 papers), Biochemical Acid Research Studies (3 papers) and Coenzyme Q10 studies and effects (2 papers). The work is most often cited by research in Complementary and alternative medicine (53 citations), Biochemistry (45 citations) and Clinical Biochemistry (39 citations). Amany A. Abdin has collaborated with scholars based in Egypt, Vietnam and United States. Frequent co-authors include Naglaa Sarhan, Amal Baalash, Eman M. Saied, Nema A. Soliman, Mohamed Balaha, Mohammed Hassanien, Dalia S. Ashour, Nehad Hawash, Asem Elfert and Hanan Soliman. Their work appears in journals such as Gastroenterology, The Journal of Urology and European Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026